These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35347801)

  • 61. Factors influencing survival after radiotherapy of nasal tumors in 130 dogs.
    LaDue TA; Dodge R; Page RL; Price GS; Hauck ML; Thrall DE
    Vet Radiol Ultrasound; 1999; 40(3):312-7. PubMed ID: 10519313
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Five-year survival outcomes of intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) using forward IMRT or Tomotherapy for breast cancer.
    Lee HH; Chen CH; Luo KH; Chuang HY; Huang CJ; Cheng YK; Chen F; Kuo SH; Huang MY
    Sci Rep; 2020 Mar; 10(1):4342. PubMed ID: 32152428
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dose escalated simultaneous integrated boost of gross nodal disease in gynecologic cancers: a multi-institutional retrospective analysis and review of the literature.
    Jensen GL; Mezera MA; Hasan S; Hammonds KP; Swanson GP; El-Ghamry MN
    Radiat Oncol J; 2021 Sep; 39(3):219-230. PubMed ID: 34610661
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hypofractionated radiotherapy in nine dogs with unresectable solitary lung adenocarcinoma.
    Kawabe M; Kitajima Y; Murakami M; Iwasaki R; Goto S; Sakai H; Mori T
    Vet Radiol Ultrasound; 2019 Jul; 60(4):456-464. PubMed ID: 31099095
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High dose simultaneous integrated boost for node positive cervical cancer.
    Jayatilakebanda I; Tsang YM; Hoskin P
    Radiat Oncol; 2021 May; 16(1):92. PubMed ID: 34001158
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Outcome and toxicity of intensity modulated radiotherapy with simultaneous integrated boost in locally advanced non-small cell lung cancer patients.
    Fondevilla Soler A; López-Guerra JL; Dzugashvili M; Sempere Rincón P; Sautbaet A; Castañeda P; Díaz JM; Praena-Fernandez JM; Rivin Del Campo E; Azinovic I
    Clin Transl Oncol; 2017 Dec; 19(12):1469-1477. PubMed ID: 28589434
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
    Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
    Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term survival with stereotactic radiotherapy for imaging-diagnosed pituitary tumors in dogs.
    Hansen KS; Zwingenberger AL; Théon AP; Kent MS
    Vet Radiol Ultrasound; 2019 Mar; 60(2):219-232. PubMed ID: 30575174
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
    Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal.
    Tomasoa NB; Meulendijks D; Nijkamp J; Cats A; Dewit L
    Acta Oncol; 2016 Jun; 55(6):760-6. PubMed ID: 26878244
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radiation Dose-escalated Chemoradiotherapy Using Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Unresectable Thoracic Oesophageal Squamous Cell Carcinoma: A Single-institution Phase I Study.
    Sakanaka K; Ishida Y; Fujii K; Ishihara Y; Nakamura M; Hiraoka M; Mizowaki T
    Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):191-201. PubMed ID: 32768158
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas.
    Cho KH; Kim JY; Lee SH; Yoo H; Shin SH; Moon SH; Kim TH; Shin KH; Yoon M; Lee DH; Pyo HR
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):390-7. PubMed ID: 20097489
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study.
    Xu Y; Zheng X; Bai X; Li P; Ma H; Wang J; Hu X; Chen M
    Oncotarget; 2017 Jul; 8(30):49084-49092. PubMed ID: 28467775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non-modulated hypofractionated radiation therapy.
    Trageser E; Martin T; Hoaglund E; Leary D; LaRue S; Boss MK
    Vet Comp Oncol; 2022 Jun; 20(2):491-501. PubMed ID: 34936172
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016).
    Gieger TL; Nolan MW
    Vet Comp Oncol; 2018 Mar; 16(1):E68-E75. PubMed ID: 28741887
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy 
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
    You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.
    Xu Y; Wang Z; Liu G; Zheng X; Wang Y; Feng W; Lai X; Zhou X; Li P; Ma H; Wang J; Hu X; Chen M
    J Cancer Res Ther; 2016 Oct; 12(Supplement):82-88. PubMed ID: 27721262
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparison of dosimetric and clinical parameters between different IMRT boost techniques in preoperative rectal cancer.
    Karaca S; Aysenur Arli Karacam K
    J BUON; 2021; 26(4):1231-1238. PubMed ID: 34564975
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
    Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
    Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
    Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
    J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.